Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.

Pychyńska-Pokorska, Magdalena

Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. [electronic resource] - Journal of cardiothoracic and vascular anesthesia Dec 2011 - 987-94 p. digital

Publication Type: Journal Article

1532-8422

10.1053/j.jvca.2011.05.012 doi


Adolescent
Aging--physiology
Anticoagulants--therapeutic use
Blood Coagulation Disorders--diagnosis
Blood Loss, Surgical
Blood Transfusion--statistics & numerical data
Cardiac Surgical Procedures--methods
Cardiopulmonary Bypass--methods
Child
Child, Preschool
Echocardiography, Transesophageal
Factor VIIa--adverse effects
Female
Heart Defects, Congenital--surgery
Hemostatics
Heparin Antagonists--therapeutic use
Humans
Infant
Infant, Newborn
Male
Off-Label Use
Partial Thromboplastin Time
Postoperative Hemorrhage--drug therapy
Protamines--therapeutic use
Prothrombin Time
Recombinant Proteins--adverse effects
Retrospective Studies
Thrombosis--diagnosis